BACKGROUND: The leading cause of asthma exacerbation is respiratory viral infection. Innate antiviral defense pathways are altered in the asthmatic epithelium, yet involvement of inflammasome signaling in virus-induced asthma exacerbation is not known. OBJECTIVE: This study compared influenza-induced activation of inflammasome and innate immune signaling in human bronchial epithelial cells from volunteers with and without asthma and investigated the role of caspase-1 in epithelial cell antiviral defense. METHODS: Differentiated primary human bronchial epithelial cells from volunteers with and without asthma were infected with influenza A virus. An inflammasome-specific quantitative real-time polymerase chain reaction array was used to compare baseline and influenza-induced gene expression profiles. Cytokine secretion, innate immune gene expression, and viral replication were compared between human bronchial epithelial cells from volunteers with and without asthma. Immunofluorescence microscopy was used to evaluate caspase-1 and PYCARD colocalization. Tracheal epithelial cells from caspase-1-deficient or wild-type mice were infected with influenza and assessed for antiviral gene expression and viral replication. RESULTS: Human bronchial epithelial cells from asthmatic volunteers had altered influenza-induced expression of inflammasome-related and innate immune signaling components, which correlated with enhanced production of IL-1β, IL-6, and TNF-α. Specifically, influenza-induced caspase-1 expression was enhanced and localization differed in human bronchial epithelial cells from asthmatic volunteers compared to volunteers without asthma. Influenza-infected tracheal epithelial cells from caspase-1-deficient mice had reduced expression of antiviral genes and viral replication. CONCLUSION: Caspase-1 plays an important role in the airway epithelial cell response to influenza infection, which is enhanced in asthmatic volunteers, and may contribute to the enhanced influenza-related pathogenesis observed in vivo.
BACKGROUND: The leading cause of asthma exacerbation is respiratory viral infection. Innate antiviral defense pathways are altered in the asthmatic epithelium, yet involvement of inflammasome signaling in virus-induced asthma exacerbation is not known. OBJECTIVE: This study compared influenza-induced activation of inflammasome and innate immune signaling in human bronchial epithelial cells from volunteers with and without asthma and investigated the role of caspase-1 in epithelial cell antiviral defense. METHODS: Differentiated primary human bronchial epithelial cells from volunteers with and without asthma were infected with influenza A virus. An inflammasome-specific quantitative real-time polymerase chain reaction array was used to compare baseline and influenza-induced gene expression profiles. Cytokine secretion, innate immune gene expression, and viral replication were compared between human bronchial epithelial cells from volunteers with and without asthma. Immunofluorescence microscopy was used to evaluate caspase-1 and PYCARD colocalization. Tracheal epithelial cells from caspase-1-deficient or wild-type mice were infected with influenza and assessed for antiviral gene expression and viral replication. RESULTS:Human bronchial epithelial cells from asthmatic volunteers had altered influenza-induced expression of inflammasome-related and innate immune signaling components, which correlated with enhanced production of IL-1β, IL-6, and TNF-α. Specifically, influenza-induced caspase-1 expression was enhanced and localization differed in human bronchial epithelial cells from asthmatic volunteers compared to volunteers without asthma. Influenza-infected tracheal epithelial cells from caspase-1-deficient mice had reduced expression of antiviral genes and viral replication. CONCLUSION:Caspase-1 plays an important role in the airway epithelial cell response to influenza infection, which is enhanced in asthmatic volunteers, and may contribute to the enhanced influenza-related pathogenesis observed in vivo.
Authors: Y A Bochkov; K M Hanson; S Keles; R A Brockman-Schneider; N N Jarjour; J E Gern Journal: Mucosal Immunol Date: 2009-08-26 Impact factor: 7.313
Authors: Tillie-Louise Hackett; Gurpreet K Singhera; Furquan Shaheen; Patrick Hayden; George R Jackson; Richard G Hegele; Stephan Van Eeden; Tony R Bai; Delbert R Dorscheid; Darryl A Knight Journal: Am J Respir Cell Mol Biol Date: 2011-06-03 Impact factor: 6.914
Authors: Hongbo Zhang; Jiadi Luo; John F Alcorn; Kong Chen; Songqing Fan; Joseph Pilewski; Aizhong Liu; Wei Chen; Jay K Kolls; Jieru Wang Journal: J Immunol Date: 2017-04-19 Impact factor: 5.422
Authors: Alexis D Payton; Alexia N Perryman; Jessica R Hoffman; Vennela Avula; Heather Wells; Carole Robinette; Neil E Alexis; Ilona Jaspers; Julia E Rager; Meghan E Rebuli Journal: Am J Physiol Lung Cell Mol Physiol Date: 2022-03-23 Impact factor: 5.464
Authors: Adam M Speen; Jessica R Hoffman; Hye-Young H Kim; Yael N Escobar; Grace E Nipp; Meghan E Rebuli; Ned A Porter; Ilona Jaspers Journal: Chem Res Toxicol Date: 2019-09-11 Impact factor: 3.739
Authors: Dhara A Patel; Yingjian You; Guangming Huang; Derek E Byers; Hyun Jik Kim; Eugene Agapov; Martin L Moore; R Stokes Peebles; Mario Castro; Kaharu Sumino; Adrian Shifren; Steven L Brody; Michael J Holtzman Journal: J Allergy Clin Immunol Date: 2014-09-09 Impact factor: 10.793